SPP1 and cancer: A recent study showed that macrophage-specific deletion of SPP1 strengthened the efficacy of anti-PD-1 treatment in liver cancer and reduced cancer-associated fibroblasts (CAFs) infiltration and increased cytotoxic T-cell infiltration (41).